Cost-Effectiveness of Blood-Based Brain Biomarkers for Screening Adults with Mild Traumatic Brain Injury in the French Health Care Setting.
Journal Information
Full Title: J Neurotrauma
Abbreviation: J Neurotrauma
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Author Disclosure Statement Dr. Earnshaw and Ms. McDade are employees, and Dr. Purser was an employee, of RTI Health Solutions, a not-for-profit contract research organization that performs health outcomes research for bioMérieux and other biotechnology, pharmaceutical, and diagnostic/medical device manufacturers. Ms. Zimmer, Ms. Blanc, Dr. Textoris, Dr. Krause, and Dr. Pavlov are employees, and Dr. Beyhaghi was an employee, of bioMérieux, one of the manufacturers of the GFAP+UCH-L1 biomarkers."
Funding Disclosure
Evidence found in paper:
"Funding Information This study was funded by bioMérieux, Inc."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025